PB
POSCO BioVentures
Micro VCActivePOSCO BioVentures' primary investment focus is on companies with novel, proprietary bio-molecules.
Carlsbad, United StatesFounded 2019
15
Investments
5
Exits
—
AUM
33.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for POSCO BioVentures.
Investment Thesis & Strategy
POSCO BioVentures invests in companies across various stages with novel, proprietary bio-molecules, focusing on the general bio-molecule industry.
Investment Activity
Deals per year over the last 2 years
1
201611
2017Portfolio Companies
Selected investments from their portfolio of 15 companies
C
Celltrion
Biotech · Growth, 2017
H
Helixmith
Biotech · Growth, 2017
G
Genexine
Biotech · Growth, 2017
V
Vaxcell BioTherapeutics
Biotech · Series A, 2017
B
BioLeaders
Biotech · Series A, 2017
A
Aprogen
Biotech · Growth, 2017
P
Peptron
Biotech · Growth, 2017
G
GenScript Biotech
Biotech · Growth, 2017
S
SillaJen
Biotech · Growth, 2017
T
ToolGen
Biotech · Growth, 2017
G
GC Cell
Biotech · Growth, 2017
O
OliX Pharmaceuticals
Biotech · Series A, 2016
Frequently Asked Questions
POSCO BioVentures focuses on Seed, Series A stage investments.
Related Investors
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals
Kima Ventures
Paris, France · 565 deals
Alumni Ventures Group
Manchester, United States · 442 deals
FundersClub
San Francisco, United States · 425 deals
Wavemaker Partners
Singapore, Singapore · 424 deals